Deployment and transcriptional evaluation of nitisinone, an FDA ‐approved drug, to control bed bugs
Pest Management Science · 2025
DOI: 10.1002/ps.8614 ↗At a glance
Journal article in Pest Management Science, 2025. Written by Marcos Sterkel and 6 co-authors. Institution: Centro Regional de Estudios Genómicos, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CENEXA, CONICET, La Plata, Argentina. Major MEDLINE topics: Bedbugs, Insecticides, Cyclohexanones, Insect Control. Cited 2 times so far (Crossref); 40 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, CONICET.
Abstract (original language)
BACKGROUND Bed bugs are blood‐feeders that rapidly proliferate into large indoor infestations. Their bites can cause allergies, secondary infections and psychological stress, among other problems. Although several tactics for their management have been used, bed bugs continue to spread worldwide wherever humans reside. This is mainly due to human‐mediated transport and their high resistance to several classes of insecticides. New treatment options with novel modes of action are required for their control. In this study, we evaluated the use of nitisinone (NTBC), an FDA‐approved drug, for bed bug control in an insecticide‐susceptible (HH) and an insecticide‐resistant (CIN) population. RESULTS Although NTBC was lethal to both populations when administered orally or applied topically in very low doses, we observed a slight but significant resistance in the CIN population. Transcriptomic analysis in both populations indicated that NTBC treatment elicited a broad suppression of genes associated with RNA post‐transcriptional modifications, translation, endomembrane system, protein post‐translational modifications and protein folding. The CIN population exhibited higher adenosine triphosphate (ATP) production and xenobiotic detoxification. Feeding studies on a mouse model suggest that NTBC could be used as a control method of bed bugs by host treatment. CONCLUSION The results indicate that NTBC can be used as a new active ingredient for bed bug control by topical or oral treatment and shed light on the molecular mechanisms of suppressed tyrosine metabolism following NTBC treatment. © 2025 Society of Chemical Industry.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Centro Regional de Estudios Genómicos, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CENEXA, CONICET, La Plata, Argentina.
- Department of Biological Sciences, University of Cincinnati, Cincinnati, OH, USA.
- Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, NC, USA.
- Departamento de Parasitologia-ICB, Laboratório de Entomologia Médica, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular, Rio de Janeiro, Brazil.
ORCID profiles: Marcos Sterkel, Coby Schal, Luiza R M Guerra, Joshua B Benoit
Funding
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- CONICET
- Fulbright Commission Argentina
- Fondo para la Investigación Científica y Tecnológica
- Consejo Nacional de Investigaciones Científicas y Técnicas
Cite
APA
Sterkel, M., Tompkin, J., Schal, C., Guerra, L. R. M., Pessoa, G. C. D., Oliveira, P. L., & Benoit, J. B. (2025). Deployment and transcriptional evaluation of nitisinone, an FDA ‐approved drug, to control bed bugs. Pest Management Science. https://doi.org/10.1002/ps.8614
Vancouver
Sterkel M, Tompkin J, Schal C, Guerra LRM, Pessoa GCD, Oliveira PL, et al. Deployment and transcriptional evaluation of nitisinone, an FDA ‐approved drug, to control bed bugs. Pest Management Science. 2025. doi:10.1002/ps.8614
BibTeX
@article{Sterkel2025,
author = {Sterkel, Marcos and Tompkin, Joshua and Schal, Coby and Guerra, Luiza R M and Pessoa, Grasielle C D and Oliveira, Pedro L and Benoit, Joshua B},
title = {Deployment and transcriptional evaluation of nitisinone, an FDA ‐approved drug, to control bed bugs},
journal = {Pest Management Science},
year = {2025},
doi = {10.1002/ps.8614}
}
EUVIMED